ExodusPoint Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

ExodusPoint Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.8M	Sell	53,201 -125,578	-70%	-$27.5M	0.08%	232
2026 Q1	$33.8M	Buy	178,779 +41,229	+30%	+$7.21M	0.27%	48
2025 Q4	$23.4M	Buy	137,550 +116,542	+555%	+$17.9M	0.18%	86
2025 Q3	$2.77M	Sell	21,008 -11,311	-35%	-$1.36M	0.03%	619
2025 Q2	$3.43M	Sell	32,319 -80,245	-71%	-$8.72M	0.03%	545
2025 Q1	$14M	Buy	+112,564	New	+$14.7M	0.14%	148
2024 Q3	–	Sell	-35,432	Closed	-$3.78M	–	1840
2024 Q2	$3.78M	Buy	+35,432	New	+$3.9M	0.03%	513
2023 Q2	–	Sell	-10,205	Closed	-$1.49M	–	2049
2023 Q1	$1.49M	Buy	+10,205	New	+$1.51M	0.01%	1000
2022 Q4	–	Sell	-30,979	Closed	-$4.13M	–	1872
2022 Q3	$4.13M	Buy	+30,979	New	+$4.71M	0.05%	472
2022 Q1	–	Sell	-12,360	Closed	-$1.57M	–	2423
2021 Q4	$1.57M	Buy	12,360 +6,853	+124%	+$901K	0.02%	860
2021 Q3	$717K	Buy	+5,507	New	+$832K	0.01%	1195
2021 Q2	–	Sell	-2,301	Closed	-$378K	–	2574
2021 Q1	$378K	Buy	+2,301	New	+$379K	0.01%	1527
2020 Q1	–	Sell	-3,592	Closed	-$536K	–	1355
2019 Q4	$536K	Buy	3,592 +95	+3%	+$12.9K	0.01%	821
2019 Q3	$448K	Sell	3,497 -713	-17%	-$95.6K	0.02%	709
2019 Q2	$600K	Buy	+4,210	New	+$566K	0.02%	397

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

ExodusPoint Capital Management's JAZZ Position: Q2 2026 in Review

ExodusPoint Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 70% in Q2 2026, selling an estimated $27.5M and leaving 53,201 shares worth $12.8M. The position accounts for 0.08% of the portfolio, ranked #232.

ExodusPoint Capital Management first reported a position in JAZZ in Q2 2019 and has held it in 15 quarters since. The position peaked at $33.8M in Q1 2026. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

ExodusPoint Capital Management held 53,201 shares of Jazz Pharmaceuticals worth $12.8M as of Q2 2026.
ExodusPoint Capital Management sold 125,578 Jazz Pharmaceuticals shares in Q2 2026, an estimated $27.5M.
Jazz Pharmaceuticals made up 0.08% of ExodusPoint Capital Management's portfolio in Q2 2026, its #232 holding.
ExodusPoint Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2019 and has held it in 15 quarters since.
ExodusPoint Capital Management's Jazz Pharmaceuticals position peaked at $33.8M in Q1 2026.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.